LeadingBiotech: Boston BD is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Reenie McCarthy
Chief Executive Officer at Stealth Biotherapeutics


Reenie McCarthy is the Chief Executive Officer and a member of the Board of Stealth BioTherapeutics. Reenie McCarthy is a 20+ year veteran of the investment team of Morningside, Stealth’s principal investor. Reenie has extensive experience working with numerous private nonclinical and clinical stage companies developing drugs across a broad spectrum of therapeutic areas and providing operational and management oversight to venture-backed technology companies. Reenie has been involved with Stealth since 2009, before stepping into a dedicated leadership role at the company in 2015. Reenie received her BA, cum laude, from Bates College and her JD from the University of Pennsylvania Law School.

Reenie McCarthy's Network

Agenda Sessions

  • The Path to an IPO: Do I Really Need to Do a Crossover Round?